Evidence map›Paper›PMID 39991570›Full record

ArticleJournal of Cancer2025

Factors Affecting Delayed Recovery from Neutropenia in Patients with Pancreatic Cancer Receiving Gemcitabine plus Nab-Paclitaxel.

Naoko Yoshida, Shungo Imai, Kazuyoshi Kawakami, Takashi Yokokawa, Masashi Nakamura, Takeshi Aoyama, Hisanori Shimizu, Ryoichi Naito, Minori Teramae, Masami Tsuchiya and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Naoko YoshidaDivision of Drug Informatics, Keio University Faculty of Pharmacy, Tokyo, Japan.
Shungo ImaiDivision of Drug Informatics, Keio University Faculty of Pharmacy, Tokyo, Japan.
Kazuyoshi KawakamiDepartment of Pharmacy, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Takashi YokokawaDepartment of Pharmacy, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Masashi NakamuraDepartment of Pharmacy, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Takeshi AoyamaDepartment of Pharmacy, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Hisanori ShimizuDepartment of Pharmacy, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Ryoichi NaitoDivision of Drug Informatics, Keio University Faculty of Pharmacy, Tokyo, Japan.
Minori TeramaeDivision of Drug Informatics, Keio University Faculty of Pharmacy, Tokyo, Japan.
Masami TsuchiyaDivision of Drug Informatics, Keio University Faculty of Pharmacy, Tokyo, Japan.
Hayato KizakiDivision of Drug Informatics, Keio University Faculty of Pharmacy, Tokyo, Japan.
Masato OzakaDepartment of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Naoki SasahiraDepartment of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Masakazu YamaguchiDepartment of Pharmacy, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Satoko HoriDivision of Drug Informatics, Keio University Faculty of Pharmacy, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

gemcitabinegranulocyte colony-stimulating factorneutropenianeutrophilpancreatic neoplasmrisk factor

Identifiers

PMID39991570
PMCPMC11843245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.